ArticleFrontiers in immunology2025

Efficacy and safety of sintilimab combined with trastuzumab and chemotherapy in HER2-positive advanced gastric or gastroesophageal junction cancer.

Zeyu Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.